Lewis C. Cantley
Beth Israel Deaconess Medical Center · 1,347 works · 206,411 citations · h-index 214
Top works
- Oncogenes and signal transduction
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
- Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity
- Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation
- PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells
- The Phosphoinositide 3-Kinase Pathway
- Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate
- Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate
- Signalling through the lipid products of phosphoinositide-3-OH kinase
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
- AKT/PKB Signaling: Navigating Downstream
- PI3K: Downstream AKTion Blocks Apoptosis
- Purification and characterization of phosphoinositide 3-kinase from rat liver.
- Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol.
- Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Implications for cellular regulation
- Activation of phosphatidylinositol 3-kinase by insulin.
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
- Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains